These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7805242)

  • 1. Experimental graft coronary artery disease in a murine heterotopic cardiac transplant model.
    Hirozane T; Matsumori A; Furukawa Y; Sasayama S
    Circulation; 1995 Jan; 91(2):386-92. PubMed ID: 7805242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental cardiac allograft vasculopathy in mice.
    Ardehali A; Billingsley A; Laks H; Drinkwater DC; Sorensen TJ; Drake TA
    J Heart Lung Transplant; 1993; 12(5):730-5. PubMed ID: 8241210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril.
    Furukawa Y; Matsumori A; Hirozane T; Sasayama S
    Circulation; 1996 Jan; 93(2):333-9. PubMed ID: 8548907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic rejection in H-2 matched cardiac allografts: early emergence of vasculopathy, alloantibody, and accumulation of IFN-gamma and IL-10 mRNA.
    Zhang QW; Tomita Y; Matsuzaki G; Uchida T; Yoshikawa M; Nakashima Y; Sueishi K; Nomoto K; Yasui H
    Transpl Int; 2001 Jun; 14(3):143-52. PubMed ID: 11499903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
    Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
    Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of murine cardiac allograft rejection with gallium nitrate. Comparison with anti-CD4 monoclonal antibody.
    Orosz CG; Wakely E; Bergese SD; VanBuskirk AM; Ferguson RM; Mullet D; Apseloff G; Gerber N
    Transplantation; 1996 Mar; 61(5):783-91. PubMed ID: 8607184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
    Koskinen PK; Lemström KB; Häyry PJ
    Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
    Soleimani B; Fu F; Lake P; Shi VC
    J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local cellular immunology of experimental transplant vascular sclerosis.
    Orosz CG
    Clin Transplant; 1996 Feb; 10(1 Pt 2):100-3. PubMed ID: 8680044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model.
    Adams DH; Tilney NL; Collins JJ; Karnovsky MJ
    Transplantation; 1992 May; 53(5):1115-9. PubMed ID: 1585476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
    Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
    J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial apoptosis in a heterotopic murine heart transplantation model of chronic rejection and graft vasculopathy.
    White WL; Zhang YL; Shelby J; Trautman MS; Perkins SL; Hammond EH; Shaddy RE
    J Heart Lung Transplant; 1997 Feb; 16(2):250-5. PubMed ID: 9059937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity to vimentin potentiates graft vasculopathy in murine cardiac allografts.
    Mahesh B; Leong HS; Nair KS; McCormack A; Sarathchandra P; Rose ML
    Transplantation; 2010 Jul; 90(1):4-13. PubMed ID: 20463646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac allograft vasculopathy in partially inbred miniature swine. I. Time course, pathology, and dependence on immune mechanisms.
    Madsen JC; Sachs DH; Fallon JT; Weissman NJ
    J Thorac Cardiovasc Surg; 1996 Jun; 111(6):1230-9. PubMed ID: 8642825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis in murine cardiac grafts.
    Bergese SD; Klenotic SM; Wakely ME; Sedmak DD; Orosz CG
    Transplantation; 1997 Jan; 63(2):320-5. PubMed ID: 9020338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic rejection in experimental cardiac transplantation: studies in the Lewis-F344 model.
    Adams DH; Russell ME; Hancock WW; Sayegh MH; Wyner LR; Karnovsky MJ
    Immunol Rev; 1993 Aug; 134():5-19. PubMed ID: 8225375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometric analysis of neointimal formation in murine cardiac grafts: III. Dissociation of intestitial fibrosis from neointimal formation.
    Armstrong AT; Strauch AR; Starling RC; Sedmak DD; Orosz CG
    Transplantation; 1997 Oct; 64(8):1198-202. PubMed ID: 9355840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.